CGB 0.00% 2.1¢ cann global limited

"As part of its drug development strategy, Medical Cannabis will...

  1. 2,331 Posts.
    lightbulb Created with Sketch. 130
    "As part of its drug development strategy, Medical Cannabis will undertake pharmacokinetic studies that compare Canntab with other medical cannabis preparations to substantiate its claim that Canntab offers an optimal and stable delivery system.

    Local clinical trials will also compare the effectiveness of Canntab against current opioid medicines in chronic non cancer pain.

    Additionally, Medical Cannabis will investigate the impact of Canntab with alcohol and other drugs."

    Sounds like a fun trial/study/party ... where do we sign up?
    Last edited by PeaceOut: 02/04/18
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.